Abstract WE574: Systematic Review and Meta-Analysis of Left-Sided Valvular Involvement in Intravenous Drug Use–Associated Infective Endocarditis

M Minh Le H Hung Phan Huu (University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, Ho Chi Minh, Viet Nam) V Vien Truong (Department of Cardiology, The Christ Hospital Health Network, Lindner Research Center, Cincinnati, Ohio, United States) M Minh Tang (Taipei Medical University, Houston, Texas, United States) K Ky Phat Nguyen (International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan) A An Thuy Vo (Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Viet Nam) L Loc Vu (School of Medicine, Tan Tao University, Long An, Viet Nam) D Duy Chung (Department of Internal Medicine, Northwest Healthcare Tucson, Tucson, Arizona, United States) C Chi Duong (Department of Biomedical&Nutritional Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, United States) Q Quoc Bui (South Texas Health System GME, McAllen, Texas, United States) H Han Huynh (Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan) T Trang Diep Thanh Le (Master Program in Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan) H Hoai Le (Cardiovascular Research Laboratories, Methodist Hospital, Merrillville, Indiana, United States) H Hien Kha (International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan) N Nhi Huu Hanh Le P Phan Dai (Mien Dong Innovative Technology University, Dong Nai, Viet Nam) D Dang Nguyen T Thu Huynh Minh Le (Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States) L Lam Chau (Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States) P Phat Huynh (North Carolina A&T State University, Greensboro, North Carolina, United States) T Thach Nguyen (Interventional Cardiology Department, Methodist Hospital and St. Mary Medical Center, Merrillville, Indiana, United States) T Thanh-Minh Nguyen (North Carolina A&T State University, Greensboro, North Carolina, United States) T Thanh-Huy Nguyen (Carnegie Mellon University, Pittsburgh, Pennsylvania, United States) J Jacques Kpodonu (Harvard Medical School, Boston, Massachusetts, United States) N Nguyen Quoc Khanh Le (Taipei Medical University, Houston, Texas, United States)

Abstract

Background: Right-sided infective endocarditis is classically linked to intravenous drug use (IVDU), yet contemporary reports suggest substantial left-sided and multivalvular disease. The true burden across valves and its clinical implications have not been quantified in a comprehensive synthesis. Hypothesis: We hypothesize that left-sided valve involvement represents a significant and underrecognized proportion of IVDU-associated infective endocarditis and is associated with higher rates of surgery and death compared with isolated right-sided disease. Methods: Following PRISMA 2020 and a PROSPERO-registered protocol (CRD420251010004), we searched PubMed, Embase, Scopus, and Web of Science (January 2021–December 2025) for studies enrolling adults (≥18 years) with echocardiography-confirmed IVDU-associated infective endocarditis. Random-effects meta-analysis (DerSimonian–Laird) estimated pooled prevalence and relative risk (RR) with 95% confidence intervals (CIs). Heterogeneity was assessed with I 2 , risk of bias with ROBINS-E, and small-study effects with funnel plots and sensitivity analyses. When reported, side-specific prevalences allowed both-sided cases to contribute to each side. Results: Fourteen studies (n=1,783 patients) met eligibility criteria. Pooled prevalence was 61% (95% confidence interval (CI)=57–65) for right-sided involvement, 41% (95% CI=35–47) for left-sided involvement, and 7% (95% CI=5–10) for both-sided disease. Valve-level involvement was tricuspid 61%, mitral 23%, aortic 17%, and pulmonic 1%. Compared with left-sided disease, right-sided involvement was more frequent (relative risk (risk ratio)=1.49; 95% CI=1.15–1.95; p=0.008). Staphylococcus aureus was the leading pathogen (73%), including methicillin-resistant strains in 17%. Valve surgery occurred in 21% and all-cause mortality in 17%. Findings were robust in leave-one-out and subgroup analyses with minimal evidence of publication bias. Conclusions: Left-sided valve involvement occurs in approximately two in five cases of IVDU-associated infective endocarditis, which is far higher than traditionally appreciated, and frequently affects the mitral and aortic valves. These data challenge the assumption of predominantly right-sided disease and support routine transesophageal echocardiography, early surgical evaluation, and integrated addiction care to improve outcomes in this high-risk population.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (25)

M

Minh Le

H

Hung Phan Huu

University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, Ho Chi Minh, Viet Nam

V

Vien Truong

Department of Cardiology, The Christ Hospital Health Network, Lindner Research Center, Cincinnati, Ohio, United States

M

Minh Tang

Taipei Medical University, Houston, Texas, United States

K

Ky Phat Nguyen

International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

A

An Thuy Vo

Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Viet Nam

L

Loc Vu

School of Medicine, Tan Tao University, Long An, Viet Nam

D

Duy Chung

Department of Internal Medicine, Northwest Healthcare Tucson, Tucson, Arizona, United States

C

Chi Duong

Department of Biomedical&Nutritional Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, United States

Q

Quoc Bui

South Texas Health System GME, McAllen, Texas, United States

H

Han Huynh

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

T

Trang Diep Thanh Le

Master Program in Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan

H

Hoai Le

Cardiovascular Research Laboratories, Methodist Hospital, Merrillville, Indiana, United States

H

Hien Kha

International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

N

Nhi Huu Hanh Le

P

Phan Dai

Mien Dong Innovative Technology University, Dong Nai, Viet Nam

D

Dang Nguyen

T

Thu Huynh Minh Le

Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States

L

Lam Chau

Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States

P

Phat Huynh

North Carolina A&T State University, Greensboro, North Carolina, United States

T

Thach Nguyen

Interventional Cardiology Department, Methodist Hospital and St. Mary Medical Center, Merrillville, Indiana, United States

T

Thanh-Minh Nguyen

North Carolina A&T State University, Greensboro, North Carolina, United States

T

Thanh-Huy Nguyen

Carnegie Mellon University, Pittsburgh, Pennsylvania, United States

J

Jacques Kpodonu

Harvard Medical School, Boston, Massachusetts, United States

N

Nguyen Quoc Khanh Le

Taipei Medical University, Houston, Texas, United States